{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:54Z","timestamp":1786982754631,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR200181"],"award-info":[{"award-number":["NIHR200181"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40258-025-00993-6","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T14:00:04Z","timestamp":1755007204000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Reconciled Method for Evaluating the Cost-Effectiveness of Implementation Programmes: Illustrated by Quality Improvement Programmes to Increase the Uptake of Magnesium Sulphate in Preterm Births"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-9247","authenticated-orcid":false,"given":"Carlos","family":"Sillero-Rejon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hollingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent C.","family":"Opmeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"993_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-50","volume":"7","author":"JM Grimshaw","year":"2012","unstructured":"Grimshaw JM, Eccles MP, Lavis JN, et al. Knowledge translation of research findings. Implement Sci. 2012;7: 50. https:\/\/doi.org\/10.1186\/1748-5908-7-50.","journal-title":"Implement Sci"},{"key":"993_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-019-0897-z","volume":"14","author":"L Hull","year":"2019","unstructured":"Hull L, Goulding L, Khadjesari Z, et al. Designing high-quality implementation research: development, application, feasibility and preliminary evaluation of the implementation science research development (ImpRes) tool and guide. Implement Sci. 2019;14: 80. https:\/\/doi.org\/10.1186\/s13012-019-0897-z.","journal-title":"Implement Sci"},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","volume":"104","author":"ZS Morris","year":"2011","unstructured":"Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104:510\u201320. https:\/\/doi.org\/10.1258\/jrsm.2011.110180.","journal-title":"J R Soc Med"},{"key":"993_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.06.008","author":"AB Eisman","year":"2020","unstructured":"Eisman AB, Kilbourne AM, Dopp AR, et al. Economic evaluation in implementation science: making the business case for implementation strategies. Psychiatry Res. 2020. https:\/\/doi.org\/10.1016\/j.psychres.2019.06.008.","journal-title":"Psychiatry Res"},{"key":"993_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-014-0168-y","volume":"9","author":"T Hoomans","year":"2014","unstructured":"Hoomans T, Severens JL. Economic evaluation of implementation strategies in health care. Implement Sci. 2014;9: 168. https:\/\/doi.org\/10.1186\/s13012-014-0168-y.","journal-title":"Implement Sci"},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.puhe.2019.01.012","volume":"169","author":"P Reeves","year":"2019","unstructured":"Reeves P, Edmunds K, Searles A, et al. Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice. Public Health. 2019;169:101\u201313. https:\/\/doi.org\/10.1016\/j.puhe.2019.01.012.","journal-title":"Public Health"},{"key":"993_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-019-0901-7","volume":"14","author":"SLE Roberts","year":"2019","unstructured":"Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields\u2014a systematic literature review. Implement Sci. 2019;14: 72. https:\/\/doi.org\/10.1186\/s13012-019-0901-7.","journal-title":"Implement Sci"},{"key":"993_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-024-01220-9","volume":"22","author":"R Heggie","year":"2024","unstructured":"Heggie R, Boyd K, Kamaruzaman H, et al. What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? A scoping review. Health Res Policy Syst. 2024;22: 134. https:\/\/doi.org\/10.1186\/s12961-024-01220-9.","journal-title":"Health Res Policy Syst"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1001\/jama.286.23.2988","volume":"286","author":"J Mason","year":"2001","unstructured":"Mason J, Freemantle N, Nazareth I, et al. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286:2988\u201392. https:\/\/doi.org\/10.1001\/jama.286.23.2988.","journal-title":"JAMA"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2337\/diacare.28.1.40","volume":"28","author":"J Mason","year":"2005","unstructured":"Mason J, Freemantle N, Gibson JM, et al. Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care. 2005;28:40\u20136. https:\/\/doi.org\/10.2337\/diacare.28.1.40.","journal-title":"Diabetes Care"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00115677-200614060-00007","volume":"14","author":"J Mason","year":"2006","unstructured":"Mason J, Young RJ, New JP, et al. Economic analysis of a telemedicine intervention to improve glycemic control in patients with diabetes mellitus: illustration of a novel analytic method. Dis Manag Health Outcomes. 2006;14:377\u201385. https:\/\/doi.org\/10.2165\/00115677-200614060-00007.","journal-title":"Dis Manag Health Outcomes"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0272989X07308751","volume":"28","author":"E Fenwick","year":"2008","unstructured":"Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Med Decis Mak. 2008;28:21\u201332. https:\/\/doi.org\/10.1177\/0272989X07308751.","journal-title":"Med Decis Mak"},{"key":"993_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1524-4733.2008.00431.x","volume":"12","author":"T Hoomans","year":"2009","unstructured":"Hoomans T, Fenwick EAL, Palmer S, et al. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value Health. 2009;12:315\u201324. https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00431.x.","journal-title":"Value Health"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/0272989X08327397","volume":"29","author":"T Hoomans","year":"2009","unstructured":"Hoomans T, Severens JL, Evers SMAA, et al. Value for money in changing clinical practice: should decisions about guidelines and implementation strategies be made sequentially or simultaneously? Med Decis Mak. 2009;29:207\u201316. https:\/\/doi.org\/10.1177\/0272989X08327397.","journal-title":"Med Decis Mak"},{"key":"993_CR15","unstructured":"Walker S, Faria R, Whyte S, et al. Getting cost-effective technologies into practice: the value of implementation: report on framework for valuing implementation initiatives. University of York and University of Sheffield. 2014. p. 1\u201326."},{"key":"993_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jval.2015.12.009","volume":"19","author":"S Whyte","year":"2016","unstructured":"Whyte S, Dixon S, Faria R, et al. Estimating the cost-effectiveness of implementation: is sufficient evidence available? Value Health. 2016;19:138\u201344. https:\/\/doi.org\/10.1016\/j.jval.2015.12.009.","journal-title":"Value Health"},{"key":"993_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0272989X16645577","volume":"37","author":"R Faria","year":"2017","unstructured":"Faria R, Walker S, Whyte S, et al. How to invest in getting cost-effective technologies into practice? A framework for value of implementation analysis applied to novel oral anticoagulants. Med Decis Making. 2017;37:148\u201361. https:\/\/doi.org\/10.1177\/0272989X16645577.","journal-title":"Med Decis Making"},{"key":"993_CR18","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University; 2015."},{"key":"993_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029596","volume":"10","author":"J Raftery","year":"2020","unstructured":"Raftery J, Williams H, Clarke A, et al. \u2018Not clinically effective but cost-effective\u2019\u2014paradoxical conclusions in randomised controlled trials with \u2018doubly null\u2019 results: a cross-sectional study. BMJ Open. 2020;10: e029596. https:\/\/doi.org\/10.1136\/bmjopen-2019-029596.","journal-title":"BMJ Open"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0272989X15614814","volume":"36","author":"L Andronis","year":"2016","unstructured":"Andronis L, Barton PM. Adjusting estimates of the expected value of information for implementation: theoretical framework and practical application. Med Decis Mak. 2016;36:296\u2013307. https:\/\/doi.org\/10.1177\/0272989X15614814.","journal-title":"Med Decis Mak"},{"key":"993_CR21","unstructured":"Developing NICE guidelines: the manual. 2014. p. 240."},{"key":"993_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40273-023-01242-1","volume":"41","author":"TM Otten","year":"2023","unstructured":"Otten TM, Grimm SE, Ramaekers B, et al. Comprehensive review of methods to assess uncertainty in health economic evaluations. Pharmacoeconomics. 2023;41:619\u201332. https:\/\/doi.org\/10.1007\/s40273-023-01242-1.","journal-title":"Pharmacoeconomics"},{"key":"993_CR23","doi-asserted-by":"crossref","unstructured":"Sillero-Rejon C, Edwards HB, Opmeer BC, et al. Demonstrating the value for money of implementing evidence-based treatment: the case for further investment in magnesium sulphate as a neuroprotectant for preterm births. 2024.","DOI":"10.21203\/rs.3.rs-5520066\/v1"},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/emermed-2015-204761","volume":"32","author":"S Goodacre","year":"2015","unstructured":"Goodacre S. Uncontrolled before-after studies: discouraged by Cochrane and the EMJ. Emerg Med J. 2015;32:507\u20138. https:\/\/doi.org\/10.1136\/emermed-2015-204761.","journal-title":"Emerg Med J"},{"key":"993_CR25","unstructured":"16.3.2 Assessing risk of bias in cluster-randomized trials. https:\/\/handbook-5-1.cochrane.org\/chapter_16\/16_3_2_assessing_risk_of_bias_in_cluster_randomized_trials.htm. Accessed 13 June 2021."},{"key":"993_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-025-01423-w","volume":"20","author":"T Donovan","year":"2025","unstructured":"Donovan T, Abell B, McPhail SM, et al. Development of an instrument (Cost-IS) to estimate costs of implementation strategies for digital health solutions: a modified e-Delphi study. Implement Sci. 2025;20: 13. https:\/\/doi.org\/10.1186\/s13012-025-01423-w.","journal-title":"Implement Sci"},{"key":"993_CR27","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2016.01.004","volume":"215","author":"TA Manuck","year":"2016","unstructured":"Manuck TA, Rice MM, Bailit JL, et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. 2016;215:103.e1-103.e14. https:\/\/doi.org\/10.1016\/j.ajog.2016.01.004.","journal-title":"Am J Obstet Gynecol"},{"key":"993_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","volume":"371","author":"S Saigal","year":"2008","unstructured":"Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371:261\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)60136-1.","journal-title":"Lancet"},{"key":"993_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00021","author":"M Stavsky","year":"2017","unstructured":"Stavsky M, Mor O, Mastrolia SA, et al. Cerebral palsy\u2014trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention. Front Pediatr. 2017. https:\/\/doi.org\/10.3389\/fped.2017.00021.","journal-title":"Front Pediatr"},{"key":"993_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.earlhumdev.2009.08.060","volume":"85","author":"TM O\u2019Shea","year":"2009","unstructured":"O\u2019Shea TM, Allred EN, Dammann O, et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009;85:719\u201325. https:\/\/doi.org\/10.1016\/j.earlhumdev.2009.08.060.","journal-title":"Early Hum Dev"},{"key":"993_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004661.pub3","author":"LW Doyle","year":"2009","unstructured":"Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009. https:\/\/doi.org\/10.1002\/14651858.CD004661.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"993_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-527","volume":"13","author":"CD Bickford","year":"2013","unstructured":"Bickford CD, Magee LA, Mitton C, et al. Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis. BMC Health Serv Res. 2013;13: 527. https:\/\/doi.org\/10.1186\/1472-6963-13-527.","journal-title":"BMC Health Serv Res"},{"key":"993_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/dmcn.13653","volume":"60","author":"STF Shih","year":"2018","unstructured":"Shih STF, Tonmukayakul U, Imms C, et al. Economic evaluation and cost of interventions for cerebral palsy: a systematic review. Dev Med Child Neurol. 2018;60:543\u201358. https:\/\/doi.org\/10.1111\/dmcn.13653.","journal-title":"Dev Med Child Neurol"},{"issue":"542","key":"993_CR34","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2011.09.004","volume":"205","author":"AG Cahill","year":"2011","unstructured":"Cahill AG, Odibo AO, Stout MJ, et al. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis. Am J Obstet Gynecol. 2011;205(542):e1-7. https:\/\/doi.org\/10.1016\/j.ajog.2011.09.004.","journal-title":"Am J Obstet Gynecol"},{"key":"993_CR35","unstructured":"National Institute for Health and Care Excellence. Preterm labour and birth. NICE guideline (NG25). 2015."},{"key":"993_CR36","doi-asserted-by":"publisher","first-page":"F176","DOI":"10.1136\/archdischild-2016-311949","volume":"102","author":"CL Lea","year":"2017","unstructured":"Lea CL, Smith-Collins A, Luyt K. Protecting the premature brain: current evidence-based strategies for minimising perinatal brain injury in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2017;102:F176\u201382. https:\/\/doi.org\/10.1136\/archdischild-2016-311949.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"993_CR37","unstructured":"National Neonatal Audit Programme (NNAP) Annual report 2018. UK: RCPH. NNAP 2018."},{"key":"993_CR38","unstructured":"PReCePT\u2014the programme | West of England AHSN. West of England Academic Health Science Network. https:\/\/www.weahsn.net\/our-work\/transforming-services-and-systems\/precept\/. Accessed 20 Jan 2021."},{"key":"993_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2020-001204","volume":"10","author":"H Edwards","year":"2021","unstructured":"Edwards H, Redaniel MT, Opmeer B, et al. Evaluating an enhanced quality improvement intervention in maternity units: precept trial protocol. BMJ Open Qual. 2021;10: e001204. https:\/\/doi.org\/10.1136\/bmjoq-2020-001204.","journal-title":"BMJ Open Qual"},{"key":"993_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/archdischild-2015-309928","volume":"101","author":"C Gale","year":"2016","unstructured":"Gale C, Morris I. The UK national neonatal research database: using neonatal data for research, quality improvement and more. Arch Dis Child Educ Pract. 2016;101:216\u20138. https:\/\/doi.org\/10.1136\/archdischild-2015-309928.","journal-title":"Arch Dis Child Educ Pract"},{"key":"993_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2022-324579","author":"HB Edwards","year":"2023","unstructured":"Edwards HB, Redaniel MT, Sillero-Rejon C, et al. National PReCePT programme: a before-and-after evaluation of the implementation of a national quality improvement programme to increase the uptake of magnesium sulfate in preterm deliveries. Arch Dis Child Fetal Neonatal Ed. 2023. https:\/\/doi.org\/10.1136\/archdischild-2022-324579.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"993_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43058-020-00001-z","volume":"1","author":"GM Curran","year":"2020","unstructured":"Curran GM. Implementation science made too simple: a teaching tool. Implement Sci Commun. 2020;1:27. https:\/\/doi.org\/10.1186\/s43058-020-00001-z.","journal-title":"Implement Sci Commun"},{"key":"993_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jval.2017.03.015","volume":"20","author":"JD Chambers","year":"2017","unstructured":"Chambers JD, Salem MN, D\u2019Cruz BN, et al. A review of empirical analyses of disinvestment initiatives. Value Health. 2017;20:909\u201318. https:\/\/doi.org\/10.1016\/j.jval.2017.03.015.","journal-title":"Value Health"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-00993-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00993-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:43:57Z","timestamp":1768041837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-00993-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-00993-6","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"27 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The PReCePT Study\u2014a cluster randomised trial evaluating the impact of an enhanced support implementation of the PReCePT quality improvement toolkit to increase the uptake of magnesium sulphate in preterm deliveries for the prevention of neurodisabilities was granted a favourable ethical opinion by the National Research Ethics Service (REC ref: 19\/HRA\/0323). The PReCePT Programme Evaluation was granted a favourable ethical opinion by the UK National Health Service Health Research Authority (HRA project ID: 260504) and the University of Bristol Faculty of Health Sciences Research Ethics Committee (FREC ref: 84582).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Anonymised individual-level data for this study are from the UK National Neonatal Research Database (NNRD). Our data sharing agreement with the NNRD prohibits sharing data extracts outside of the University of Bristol research team. The NNRD data dictionary is available online, and copies of the statistical analysis plan are available in the University of Bristol\u2019s institutional repository (\n                      \n                      -\n                      ). Analysis code can be made available upon inquiry to the corresponding author.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}},{"value":"C.S.R., W.H., B.O. and H.M. led the health economic design and analysis plans, with contributions from K.L. C.S.R., W.H. and H.M. performed the health economic analysis and interpretation. C.S.R. wrote the original manuscript. All authors (C.S.R., W.H., B.O., K.L. and H.M.) reviewed the manuscript and approved the submission. K.L. was the chief investigator and guarantor of PReCePT studies.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}